434 completed, 58 unknown, 42 terminated, 17 recruiting. 594 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 594 | Completed 434, Unknown 58, Terminated 42, Recruiting 17, Withdrawn 16, Active not recruiting 15, Not yet recruiting 10, Enrolling by invitation 2 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevent Wheeze Trial Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing | Phase 4 | Not yet recruiting | Norwegian University of Science and Technology | 486 | 2027-02-01 | 2026-10-05 |
| Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma | Phase 4 | Not yet recruiting | University of Wisconsin, Madison | 20 | 2026-11-01 | 2026-09-24 |
| Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD Gabapentin, Benzonatate 200 mg, Standard of care treatment for ILD - Interstitial Lung Disease | Phase 4 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 177 | 2026-10-07 | 2026-10-08 |
| A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis Fluticasone propionate - Rhinitis Allergic, Rhinitis Seasonal | Phase 4 | Not yet recruiting | HALEON | 16 | 2026-09-01 | 2026-09-14 |
| Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic Rhinitis Mometasone Furoate Nasal spray, Loratadine 10 Mg, Montelukast 10 mg - Allergic Rhinitis (AR) | Phase 4 | Not yet recruiting | Liaquat National Hospital & Medical College | 32 | 2026-09-01 | 2026-04-16 |
| Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice ALK Alutard SQ Dog - Allergic Rhinitis, Asthma (Diagnosis) | Phase 4 | Recruiting | Karolinska Institutet | 40 | 2026-08-01 | 2026-06-29 |
| Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department Dexamethasone 16mg IM, Prednisone 60mg PO - Asthma | Phase 4 | Recruiting | Montefiore Medical Center | 182 | 2026-07-23 | 2026-07-24 |
| Fasenra: An Asthma Study Budesonide-albuterol, Benralizumab - Eosinophilic Asthma, Severe Asthma | Phase 4 | Enrolling by invitation | Endeavor Health | 40 | 2026-07-01 | 2026-09-15 |
| BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg]) Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation), Foster® 200/6 pMDI (BDP/FF-200/6 µg) - Asthma | Phase 4 | Recruiting | Chiesi Farmaceutici S.p.A. | 644 | 2026-06-28 | 2026-07-31 |
| Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA) Tezepelumab, Placebo - Severe Asthma | Phase 4 | Recruiting | University of Alberta | 100 | 2026-05-11 | 2026-07-17 |
| Dymista in Chinese Adolescents Treatment with 137 µg azelastine hydrochloride and 50 μg of fluticasone propionate - Allergic Rhinitis Due to Allergens | Phase 4 | Active not recruiting | Viatris Inc. | 100 | 2026-05-08 | 2026-09-29 |
| Ventilation and Perfusion in Asthmatics Albuterol Sulfate, Albuterol-Budesonide - Asthma | Phase 4 | Recruiting | University of Miami | 40 | 2026-04-27 | 2026-10-23 |
| CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma Implementation bundle - Moderate to Severe Asthma | Phase 4 | Recruiting | Washington University School of Medicine | 2000 | 2026-01-06 | 2026-09-10 |
| A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment, Intranasal corticosteroids (INCS) combined with nasal antihistamines (INAH) used for treatment. - Allergic Rhinitis | Phase 4 | Not yet recruiting | China-Japan Union Hospital | 50 | 2026-01-01 | 2025-12-19 |
| Withdrawal of Dupilumab in Severe Asthma Stopping dupilumab - Severe Asthma | Phase 4 | Recruiting | University Hospital, Toulouse | 205 | 2025-12-15 | 2026-10-08 |
| 45th Multicenter Airway Research Collaboration Airsupra - Asthma Acute, Asthma Exacerbation | Phase 4 | Recruiting | Massachusetts General Hospital | 1860 | 2025-11-07 | 2026-04-17 |
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA Mepolizumab 100 MG Injection [Nucala], Mepolizumab 300 mg - EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma | Phase 4 | Enrolling by invitation | Azienda Ospedaliero Universitaria di Cagliari | 90 | 2025-10-17 | 2026-01-15 |
| IV DEXAMETHASONE VS. METHYLPREDNISOLONE IN CHILDREN WITH SEVERE ASTHMA EXACERBATION Intravenous Dexamethasone, Intravenous Methylprednisolone - Status Asthmaticus, Asthma (Diagnosis) | Phase 4 | Completed | Istanbul Medeniyet University | 129 | 2025-09-01 | 2026-07-28 |
| Individualizing Treatment for Asthma in Primary Care (Full Study) Inhaled corticosteroid (ICS), Azithromycin, Asthma Symptom Monitoring Web-based Application - Asthma, Asthma Attack | Phase 4 | Recruiting | DARTNet Institute | 3200 | 2025-08-01 | 2025-10-29 |
| Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above Fexofenadine HCL and pseudoephedrine HCL - Rhinitis Allergic | Phase 4 | Completed | Sanofi | 203 | 2025-06-15 | 2026-02-17 |
Showing 20 of 594. Sign in to see all of them.
Asthma (430) · Rhinitis, Allergic (96) · Rhinitis, Allergic, Seasonal (53) · Rhinitis, Allergic, Perennial (34) · Pulmonary Disease, Chronic Obstructive (25) · Pulmonary Eosinophilia (15) · Hypersensitivity (14) · Rhinitis (13) · Respiratory Sounds (10) · Emergencies (9) · Cough-Variant Asthma (8) · Asthma, Exercise-Induced (7) · Inflammation (6) · Status Asthmaticus (6)
Hypersensitivity, Immediate (593) · Immune System Diseases (591) · Respiratory Tract Diseases (591) · Hypersensitivity (580) · Bronchial Diseases (439) · Lung Diseases (434) · Lung Diseases, Obstructive (433) · Otorhinolaryngologic Diseases (173) · Nose Diseases (171) · Rhinitis (155) · Pathological Conditions, Signs and Symptoms (74) · Rhinitis, Allergic (71) · Pathologic Processes (46) · Disease Attributes (35)
Fluticasone (66) · montelukast (55) · Albuterol (48) · Budesonide (43) · Fluticasone-Salmeterol Drug Combination (34) · Omalizumab (26) · Mometasone Furoate (23) · Salmeterol Xinafoate (22) · fexofenadine (17) · levocetirizine (17) · Beclomethasone (16) · Formoterol Fumarate (16) · fluticasone furoate (14) · Budesonide, Formoterol Fumarate Drug Combination (13) · desloratadine (13)
GlaxoSmithKline (65) · Organon and Co (36) · AstraZeneca (25) · University of Dundee (15) · Sanofi (13) · Medical University of Lodz (12) · University of Saskatchewan (12) · University of Chicago (11) · Centre of Chinese Medicine, Georgia (8) · Imperial College London (8) · Novartis Pharmaceuticals (7) · Bispebjerg Hospital (6) · Boehringer Ingelheim (6) · Novartis (6) · Teva Branded Pharmaceutical Products R&D, Inc. (6)
United States (200) · Canada (69) · United Kingdom (55) · Germany (36) · Italy (32) · China (29) · Poland (26) · Denmark (23) · Netherlands (23) · France (22) · Spain (22) · Belgium (21) · Sweden (17) · Turkey (Türkiye) (12) · Argentina (11)
Don Cockcroft, MD (6) · Iwona Stelmach, MD, PhD, Prof (6) · Manana Tchaia, MD (6) · Merab Lomia, MD, PhD (6) · Brian Lipworth, MD (5) · Phyllis Diener (5) · Robert M Naclerio, MD (5) · Leslie Hendeles, PharmD (4) · Tamara Tchelidze, MD (4)
PMID 18331513, PMID 20167147, PMID 20642206, PMID 32298853, PMID 33369570, PMID 36472162, PMID 37347518, PMID 37536444, PMID 37952772, PMID 10109801, PMID 11113831, PMID 11558866, PMID 11825832, PMID 12045120, PMID 12612294, PMID 15823451, PMID 15922813, PMID 16140398, PMID 16226443, PMID 16278257, PMID 16478839, PMID 16597501, PMID 16687712, PMID 16846553, PMID 16913264, PMID 17046300, PMID 17075269, PMID 17507702, PMID 17610727, PMID 17629923, PMID 17766511, PMID 18399898, PMID 18430310, PMID 18583517, PMID 18951618, PMID 18990678, PMID 19127072, PMID 19134016, PMID 19164187, PMID 19187327, PMID 19291931, PMID 19428097, PMID 19467341, PMID 19496252, PMID 19504468, PMID 19557208, PMID 19632710, PMID 19663124, PMID 19696440, PMID 19788025
2019 (6), 2015 (5), 2014 (3), 2017 (3), 2004 (2), 2005 (2), 2016 (2), 2018 (2), 2025 (2), 2023 (1), K23HL171940 (1), P01HL128191 (1), P50HL056385 (1), R01HL080414 (1), R01HL114899 (1)